Although the molecular mechanisms underlying the nuclear translocation of NFAT5 were not explored in the present study, our data show that IBC and nIBC phenotypes are biologically distinct and NFAT5 could serve as surrogate biomarker in an immunohistochemical assay. Here, NFAT5 is linked to inflammatory breast carcinoma.